Jason Clint Swanner, MD | |
700 18th St S Ste 410, Birmingham, AL 35233-3805 | |
(205) 325-8620 | |
Not Available |
Full Name | Jason Clint Swanner |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 26 Years |
Location | 700 18th St S Ste 410, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679593719 | NPI | - | NPPES |
051513887 | Other | AL | BLUE CROSS |
926035 | Other | AL | BLOCK VISION |
127525 | Medicaid | AL | |
H63424 | Other | AL | HEALTHSPRING OF ALABAMA |
051513887 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 22866 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Callahan Eye Hospital | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Alabama Ophthalmology Services Foundation | 9234023417 | 35 |
News Archive
Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections and different medical conditions at early stages.
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
Research has devised specific parameters that could help to classify certain foods as "hyper-palatable".
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.
› Verified 5 days ago
Entity Name | University Of Alabama Ophthalmology Services Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265485999 PECOS PAC ID: 9234023417 Enrollment ID: O20040210000034 |
News Archive
Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections and different medical conditions at early stages.
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
Research has devised specific parameters that could help to classify certain foods as "hyper-palatable".
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.
› Verified 5 days ago
Entity Name | Florence Ophthalmology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932314473 PECOS PAC ID: 7911924238 Enrollment ID: O20051026000797 |
News Archive
Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections and different medical conditions at early stages.
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
Research has devised specific parameters that could help to classify certain foods as "hyper-palatable".
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.
› Verified 5 days ago
Entity Name | Medical West Hospital Authority, An Affiliate Of Uab Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952483729 PECOS PAC ID: 6406865427 Enrollment ID: O20061204000666 |
News Archive
Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections and different medical conditions at early stages.
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
Research has devised specific parameters that could help to classify certain foods as "hyper-palatable".
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Jason Clint Swanner, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Jason Clint Swanner, MD 700 18th St S Ste 410, Birmingham, AL 35233-3805 Ph: (205) 325-8620 |
News Archive
Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections and different medical conditions at early stages.
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
Research has devised specific parameters that could help to classify certain foods as "hyper-palatable".
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.
› Verified 5 days ago
Carol E Rosenstiel, OD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 200, Birmingham, AL 35233 Phone: 205-325-8620 | |
Alex J Wright, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1720 University Blvd, Birmingham, AL 35233 Phone: 205-325-8100 Fax: 205-325-8547 | |
Elmar M Lawaczeck, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1009 Montgomery Hwy, Suite 200, Birmingham, AL 35216 Phone: 205-397-9400 Fax: 205-397-9455 | |
Matthew Henry Oltmanns, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2208 University Blvd Ste 101, Birmingham, AL 35233 Phone: 205-933-2625 Fax: 205-558-2553 | |
Harold Augustus Helms, MD, PHD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 23rd St S, Ste 100, Birmingham, AL 35205 Phone: 205-933-2020 Fax: 205-933-0908 | |
Krupa Hasmukh Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-325-8620 | |
William Charles Gambla, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-996-8660 |